Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clene (CLNN) Cash & Equivalents (2019 - 2025)

Clene has reported Cash & Equivalents over the past 7 years, most recently at $5.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 57.31% year-over-year to $5.2 million; the TTM value through Dec 2025 reached $5.2 million, down 57.31%, while the annual FY2025 figure was $5.2 million, 57.31% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $5.2 million at Clene, down from $7.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $63.0 million in Q2 2021 and troughed at $5.2 million in Q4 2025.
  • A 5-year average of $25.3 million and a median of $18.4 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 814.6% in 2021 and later tumbled 88.49% in 2022.
  • Year by year, Cash & Equivalents stood at $50.3 million in 2021, then tumbled by 63.55% to $18.3 million in 2022, then skyrocketed by 57.22% to $28.8 million in 2023, then plummeted by 57.83% to $12.2 million in 2024, then crashed by 57.31% to $5.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for CLNN at $5.2 million in Q4 2025, $7.9 million in Q3 2025, and $7.3 million in Q2 2025.